Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
                            本研究公开了
抑制剂化合物。这些化合物可有效治疗白细胞介素 1 β 活性相关的疾病或病症。此外,还公开了这些化合物的合成方法以及包含这些化合物的药物组合物。